9 Meters Biopharma Overview
9 Meters Biopharma (NMTRQ) has a ROE of 790.59%, above the Technology sector average of 47.61%.
Get informed when a big investor buys or sells
+ Follow790.59%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, NMTRQ shows a ROE of 790.59%. That is above the Technology sector average of 47.61%. Scroll down for historical charts and peer comparison views.
The Technology sector average ROE is about 47.61%. 9 Meters Biopharma is at 790.59%, which is higher that average. That is roughly 1560.7% above the sector mean. Use the comparison chart on this page to see how NMTRQ stacks up against individual peers as well.
Check the historical chart to see whether NMTRQ's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare 9 Meters Biopharma with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has 9 Meters Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 790.59%) with ownership activity and broader fundamentals.
The Technology average ROE is about 47.61%, while NMTRQ is at 790.59%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
